Published in Thorax on April 01, 1988
The role for medical thoracoscopy in pneumothorax. J Thorac Dis (2014) 0.93
Bedside pleuroscopy in Taiwan : a great vision for critically-ill patients and intensivists. Biomedicine (Taipei) (2016) 0.80
Malignant mesothelioma. J R Soc Med (1989) 0.79
Diagnostic Yield of Medical Thoracoscopy in Undiagnosed Pleural Effusion. Tanaffos (2015) 0.75
Diagnostic Utility of Pleural Fluid Cell Block versus Pleural Biopsy Collected by Flex-Rigid Pleuroscopy for Malignant Pleural Disease: A Single Center Retrospective Analysis. PLoS One (2016) 0.75
Medical Thoracoscopy Performed Using a Flexible Bronchoscope Inserted through a Chest Tube under Local Anesthesia. Diagn Ther Endosc (2009) 0.75
Malignant mesothelioma of the pleura: relation between histological type and clinical behaviour. Thorax (1982) 1.76
Thoracoscopy in the diagnosis of pleural effusion. Thorax (1977) 1.12
An analysis of the first 300 fibreoptic bronchoscopies at the Brompton Hospital. Br J Dis Chest (1979) 1.11
Thoracoscopy in malignant pleural effusions. Am Rev Respir Dis (1981) 1.07
Thoracoscopy. A safe, accurate diagnostic procedure using the rigid thoracoscope and local anesthesia. Chest (1979) 1.07
Malignant mesothelioma of the pleura in Barrow-in-Furness. Thorax (1978) 1.04
Complications of thoracoscopy. Poumon Coeur (1981) 1.04
Diagnostic thoracoscopy. Eur J Respir Dis (1981) 1.01
Diagnostic thoracoscopy. Ann Thorac Surg (1973) 1.00
Direct diagnostic thoracoscopy. Ann Thorac Surg (1976) 0.92
[Differential diagnosis of pleural effusion using thoracoscopy]. Pneumonologie (1971) 0.90
The use of thoracoscopy in the diagnosis of pleural disease. Arch Surg (1980) 0.89
Thoracoscopy in perspective. Surg Gynecol Obstet (1978) 0.82
Pleuroscopy and pleural biopsy with the flexible fiberoptic bronchoscope. Chest (1975) 0.80
Fiberoptic thoracoscopy. N Y State J Med (1975) 0.80
[Thoracoscopy in pleural mesothelioma. Diagnostic, prognostic and therapeutic interest (author's transl)]. Rev Fr Mal Respir (1979) 0.79
Two-, six-, and 12-minute walking tests in respiratory disease. Br Med J (Clin Res Ed) (1982) 7.77
The new World Health Organization classification of lung tumours. Eur Respir J (2001) 6.91
Oxygen relieves breathlessness in "pink puffers". Lancet (1981) 3.64
Oat-cell carcinoma of the lung. Its origin and relationship to bronchial carcinoid. Cancer (1968) 2.94
Pulmonary fibrosis associated with hypersensitivity to gold salts. Br Med J (1976) 2.91
Progressive airway obliteration in adults and its association with rheumatoid disease. Q J Med (1977) 2.83
The natural history of lung cancer: a review based on rates of tumour growth. Br J Dis Chest (1979) 2.76
Drug treatment of breathlessness: contrasting effects of diazepam and promethazine in pink puffers. Br Med J (Clin Res Ed) (1981) 2.74
Cystic fibrosis in the mouse by targeted insertional mutagenesis. Nature (1992) 2.66
Prognostic significance of laboratory parameters measured at diagnosis in small cell carcinoma of the lung. Cancer Res (1985) 2.62
Pulmonary lymphangiomyomatosis. A review. Am J Pathol (1975) 2.46
Theophylline prescribing, serum concentrations, and toxicity. Lancet (1983) 2.40
Radiotherapy in small cell cancer of the lung treated with combination chemotherapy: a controlled trial. Br Med J (Clin Res Ed) (1984) 2.19
Inhaled corticosteroids: benefits and risks. Thorax (1992) 2.17
Protocols for in vivo measurement of the ion transport defects in cystic fibrosis nasal epithelium. Eur Respir J (1994) 2.07
Experimental paraquat poisoning: a histological and electron-optical study of the changes in the lung. J Pathol (1971) 1.96
Effects of dihydrocodeine, alcohol, and caffeine on breathlessness and exercise tolerance in patients with chronic obstructive lung disease and normal blood gases. N Engl J Med (1981) 1.94
An MTP inhibitor that normalizes atherogenic lipoprotein levels in WHHL rabbits. Science (1998) 1.93
Amphotericin B lipid complex therapy of experimental fungal infections in mice. Antimicrob Agents Chemother (1991) 1.88
Epithelial-myoepithelial carcinomas of the bronchus. Am J Surg Pathol (2001) 1.85
p53 and chromosome 3 abnormalities, characteristic of malignant lung tumours, are detectable in preinvasive lesions of the bronchus. Oncogene (1992) 1.84
Duration of chemotherapy in small cell lung cancer: a Cancer Research Campaign trial. Br J Cancer (1989) 1.81
Medium term treatment of stable stage cystic fibrosis with recombinant human DNase I. Thorax (1995) 1.72
Correlation between fibre content of the lung and disease in east London asbestos factory workers. Br J Ind Med (1988) 1.72
Efficient gene transfer to airway epithelium using recombinant Sendai virus. Nat Biotechnol (2000) 1.71
alpha 1-antitrypsin phenotypes in fibrosing alveolitis and rheumatoid arthritis. Lancet (1977) 1.70
Absorption of glycine and glycine peptides from the small intestine of the rat. Clin Sci (1968) 1.69
Cationic lipid-mediated CFTR gene transfer to the lungs and nose of patients with cystic fibrosis: a double-blind placebo-controlled trial. Lancet (1999) 1.69
Pseudo-steroid resistant asthma. Thorax (1999) 1.67
Atelectasis and survival after bronchoscopic lung volume reduction for COPD. Eur Respir J (2010) 1.65
Histogenesis of the so-called "intravascular bronchioloalveolar tumour". J Pathol (1979) 1.61
BOOP and COP. Thorax (1991) 1.57
Effect of inhaled furosemide on metabisulfite- and methacholine-induced bronchoconstriction and nasal potential difference in asthmatic subjects. Am Rev Respir Dis (1990) 1.57
Silicosis in a Himalayan village population: role of environmental dust. Thorax (1991) 1.57
Non-invasive liposome-mediated gene delivery can correct the ion transport defect in cystic fibrosis mutant mice. Nat Genet (1993) 1.55
Inflammation in cystic fibrosis airways: relationship to increased bacterial adherence. Eur Respir J (2001) 1.55
Mannose-binding lectin is present in the infected airway: a possible pulmonary defence mechanism. Thorax (2008) 1.54
Lung tumours and ACTH production. Clin Endocrinol (Oxf) (1977) 1.54
Unusual sclerosing haemangiomas and sclerosing haemangioma-like lesions, and the value of TTF-1 in making the diagnosis. Histopathology (2002) 1.53
Mesenchymoma of the lung (so called hamartoma): a review of 154 parenchymal and endobronchial cases. Thorax (1987) 1.51
Anaerobic subareolar breast abscess. Lancet (1979) 1.49
Pleural mesothelioma resulting from exposure to amosite asbestos in a building. Respir Med (1989) 1.44
High-risk obstetric patients. Maternal morbidity after cesareans. J Reprod Med (1997) 1.43
Malignant mesothelioma in south east England: clinicopathological experience of 272 cases. Thorax (1997) 1.43
Collateral ventilation. Thorax (2006) 1.42
Expression of endothelin-1 in lungs of patients with cryptogenic fibrosing alveolitis. Lancet (1993) 1.42
Double primary localized fibrous tumours of the pleura and retroperitoneum. Histopathology (1993) 1.41
Structural features of interstitial lung disease in systemic sclerosis. Am Rev Respir Dis (1991) 1.41
Inhaled corticosteroids: benefits and risks. J Asthma (1996) 1.39
Prominent pericardial and myocardial lesions in the Churg-Strauss syndrome (allergic granulomatosis and angiitis). Thorax (1983) 1.39
Nedocromil sodium workshop. Respir Med (1989) 1.38
Wegener's granuloma. A series of 265 British cases seen between 1975 and 1985. A report by a sub-committee of the British Thoracic Society Research Committee. Q J Med (1992) 1.37
Sites of implantation for central venous access devices (ports): a study of the experiences and preferences of patients. Eur J Vasc Endovasc Surg (2004) 1.37
Pseudoexfoliation in South India. Br J Ophthalmol (2003) 1.37
Treating patients with asthma who are dependent on systemic steroids. BMJ (1989) 1.37
Bronchoscopic and percutaneous aspiration biopsy in the diagnosis of bronchial carcinoma cell type. Thorax (1982) 1.36
Oat cell carcinoma of the pancreas with ectopic ACTH secretion. Cancer (1973) 1.35
Dieulafoy's disease of the bronchus. Thorax (1995) 1.35
Patients at risk of chemotherapy-associated toxicity in small cell lung cancer. Br J Cancer (1989) 1.32
Reactive pulmonary lymphoid disorders. Histopathology (1995) 1.32
Dihydrocodeine for breathlessness in "pink puffers". Br Med J (Clin Res Ed) (1983) 1.32
Nasal potential difference: a clinical diagnostic test for cystic fibrosis. Eur Respir J (1990) 1.32
Airways obstruction in rheumatoid arthritis. Ann Rheum Dis (1979) 1.31
Ultrastructural changes in bronchoalveolar lavage cells in sarcoidosis and comparison with the tissue granuloma. Am J Pathol (1983) 1.31
FGF-2 enhances intestinal stem cell survival and its expression is induced after radiation injury. Am J Physiol (1999) 1.30
Newly diagnosed cystic fibrosis in middle and later life. Thorax (1985) 1.30
Inter-observer variation between pathologists in diffuse parenchymal lung disease. Thorax (2004) 1.29
Interstitial lung disease and asthma in hard-metal workers: bronchoalveolar lavage, ultrastructural, and analytical findings and results of bronchial provocation tests. Thorax (1983) 1.28
Pulmonary histiocytosis X. Am Rev Respir Dis (1978) 1.28
Fibreoptic bronchoscopy: effect of multiple bronchial biopsies on diagnostic yield in bronchial carcinoma. Thorax (1982) 1.27
Fine structural changes in cryptogenic fibrosing alveolitis and asbestosis. J Pathol (1985) 1.25
Reproducibility of the WHO/IASLC grading system for pre-invasive squamous lesions of the bronchus: a study of inter-observer and intra-observer variation. Histopathology (2001) 1.24
Ultrastructural immunocytochemical localisation of lysozyme in human bronchial glands. Thorax (1977) 1.23
Diagnosis and management of alveolar proteinosis: the rôle of electron microscopy. Thorax (1975) 1.23
Upper respiratory tract viral infection and mucociliary clearance. Eur J Respir Dis (1987) 1.23
High resolution computed tomography as a predictor of lung histology in systemic sclerosis. Thorax (1992) 1.23
Pulmonary veno-occlusion--an immune complex disease? Virchows Arch A Pathol Anat Histol (1974) 1.21
Second primary lung cancer: importance of long term follow up. Thorax (1989) 1.21
Spinal cord compression in small cell lung cancer: a retrospective study of 610 patients. Br J Cancer (1989) 1.20
A randomised trial of planned versus as required chemotherapy in small cell lung cancer: a Cancer Research Campaign trial. Br J Cancer (1991) 1.19
Chronic necrotising pneumonia caused by Aspergillus niger. Thorax (1989) 1.19
Supplemental oxygen and exercise ability in chronic obstructive airways disease. Thorax (1988) 1.19
Keratinocyte growth factor therapy in murine oleic acid-induced acute lung injury. Am J Physiol Lung Cell Mol Physiol (2005) 1.18
No added benefit from nebulized amiloride in patients with cystic fibrosis. Eur Respir J (1993) 1.18
Pulmonary histiocytosis simulating desquamative interstitial pneumonia in rats receiving oral iprindole. J Pathol (1972) 1.16
Biochemical and histological changes in pulmonary fibrosis induced in rabbits with intratracheal bleomycin. Eur J Clin Invest (1981) 1.15
Airway surface pH in subjects with cystic fibrosis. Eur Respir J (2003) 1.15
Randomised, double-blind, placebo-controlled trial of methotrexate in steroid-dependent asthma. Lancet (1990) 1.14
Nasal epithelial ion transport and genetic analysis of infertile men with congenital bilateral absence of the vas deferens. Hum Mol Genet (1993) 1.14
Sendai virus-mediated CFTR gene transfer to the airway epithelium. Gene Ther (2007) 1.13
Immunocytochemical localization of neuron specific enolase in small cell carcinomas and carcinoid tumours of the lung. Histopathology (1984) 1.13
Two years experience with recombinant human DNase I in the treatment of pulmonary disease in cystic fibrosis. Respir Med (1995) 1.13
How reliable is the diagnosis of lung cancer using small biopsy specimens? Report of a UKCCCR Lung Cancer Working Party. Thorax (1993) 1.13
Asbestosis: assessment by bronchoalveolar lavage and measurement of pulmonary epithelial permeability. Thorax (1985) 1.12
Electron microscopic studies in desquamative interstitial pneumonia associated with asbestos. Thorax (1972) 1.12